Professor Sir Alimuddin Zumla
Cited by
Cited by
Global burden of tuberculosis: estimated incidence, prevalence, and mortality by country
C Dye, S Scheele, V Pathania, MC Raviglione
Jama 282 (7), 677-686, 1999
Manson's Tropical Diseases
G Cook, A Zumla
Harcourt Brace Saunders Publishing Group, London 21, 1,0847, 2003
Real-time RT-PCR normalisation; strategies and considerations
J Huggett, K Dheda, S Bustin, A Zumla
Genes & Immunity 6 (4), 279-284, 2005
Global surveillance for antituberculosis-drug resistance, 1994–1997
A Pablos-MÚndez, MC Raviglione, A Laszlo, N Binkin, HL Rieder, ...
New England Journal of Medicine 338 (23), 1641-1649, 1998
Validation of housekeeping genes for normalizing RNA expression in real-time PCR
K Dheda, JF Huggett, SA Bustin, MA Johnson, G Rook, A Zumla
Biotechniques 37 (1), 112-119, 2004
Hospital outbreak of Middle East respiratory syndrome coronavirus
A Assiri, A McGeer, TM Perl, CS Price, AA Al Rabeeah, DAT Cummings, ...
New England Journal of Medicine 369 (5), 407-416, 2013
The natural history of childhood intra-thoracic tuberculosis: a critical review of literature from the pre-chemotherapy era [State of the Art]
BJ Marais, RP Gie, HS Schaaf, AC Hesseling, CC Obihara, JJ Starke, ...
The International Journal of Tuberculosis and Lung Disease 8 (4), 392-402, 2004
Advances in the development of new tuberculosis drugs and treatment regimens
A Zumla, P Nahid, ST Cole
Nature reviews Drug discovery 12 (5), 388-404, 2013
Epidemiological, demographic, and clinical characteristics of 47 cases of Middle East respiratory syndrome coronavirus disease from Saudi Arabia: a descriptive study
A Assiri, JA Al-Tawfiq, AA Al-Rabeeah, FA Al-Rabiah, S Al-Hajjar, ...
The Lancet infectious diseases 13 (9), 752-761, 2013
Best drug treatment for multidrug-resistant and extensively drug-resistant tuberculosis
JA Caminero, G Sotgiu, A Zumla, GB Migliori
The Lancet infectious diseases 10 (9), 621-629, 2010
The implications of using an inappropriate reference gene for real-time reverse transcription PCR data normalization
K Dheda, JF Huggett, JS Chang, LU Kim, SA Bustin, MA Johnson, ...
Analytical biochemistry 344 (1), 141-143, 2005
Official American thoracic society/centers for disease control and prevention/infectious diseases society of America clinical practice guidelines: treatment of drug-susceptibleá…
P Nahid, SE Dorman, N Alipanah, PM Barry, JL Brozek, A Cattamanchi, ...
Clinical Infectious Diseases 63 (7), e147-e195, 2016
Multidrug resistant pulmonary tuberculosis treatment regimens and patient outcomes: an individual patient data meta-analysis of 9,153 patients
SD Ahuja, D Ashkin, M Avendano, R Banerjee, M Bauer, JN Bayona, ...
PLoS medicine 9 (8), 2012
Middle East respiratory syndrome
A Zumla, DS Hui, S Perlman
The Lancet 386 (9997), 995-1007, 2015
Biomarkers and diagnostics for tuberculosis: progress, needs, and translation into practice
RS Wallis, M Pai, D Menzies, TM Doherty, G Walzl, MD Perkins, A Zumla
The Lancet 375 (9729), 1920-1937, 2010
A critical review of interventions to redress the inequitable distribution of healthcare professionals to rural and remote areas
N Wilson, I Couper, E de Vries, S Reid, T Fish, B Marais
Honey-a remedy rediscovered
A Zumla, A Lulat
Journal of the Royal Society of Medicine 82 (7), 384-385, 1989
Immunological biomarkers of tuberculosis
G Walzl, K Ronacher, W Hanekom, TJ Scriba, A Zumla
Nature Reviews Immunology 11 (5), 343-354, 2011
Latent Mycobacterium tuberculosis Infection
H Getahun, A Matteelli, RE Chaisson, M Raviglione
New England Journal of Medicine 372 (22), 2127-2135, 2015
The risk of tuberculosis related to tumour necrosis factor antagonist therapies: a TBNET consensus statement
I Solovic, M Sester, JJ Gomez-Reino, HL Rieder, S Ehlers, HJ Milburn, ...
European Respiratory Journal 36 (5), 1185-1206, 2010
The system can't perform the operation now. Try again later.
Articles 1–20